(Q42262709)

19 October 2017

Stimulation of nonspecific host resistance to infection induced by muramyldipeptides (English)

1 reference

19 October 2017

1 reference

Matsumoto K

1

1 reference

19 October 2017

Ogawa H

2

1 reference

19 October 2017

Nagase O

3

1 reference

19 October 2017

Kusama T

4

1 reference

19 October 2017

Azuma I

5

1 reference

19 October 2017

1 January 1981

1 reference

Microbiology and Immunology

19 October 2017

1 reference

19 October 2017

25

1 reference

19 October 2017

1047-1058

1 reference

19 October 2017

10

1 reference

Adjuvant activity of monomeric bacterial cell wall peptidoglycans.

19 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Investigations in Mice on the Potentiation of Resistance to Infections by a New Immunostimulant Compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

The host response to Calmette-Guérin bacillus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Adjuvant Protection against Bacterial Infection in Granulocytopenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Modulation of the immune response by a synthetic adjuvant and analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

The Pyrogenicity of the Synthetic Adjuvant Muramyl Dipeptide and Two Structural Analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections I. Protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Nonspecific resistance to infection induced in mice by a water-soluble adjuvant derived from Mycobacterium smegmatis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Immunostimulation with bacterial phospholipid extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Immunomodulation of Host Resistance to Experimental Viral Infections in Mice: Effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

In Vivo and in Vitro Stimulation of Nonspecific Immunity by the -D-p-Aminophenyl Glycoside of N-Acetylmuramyl-L-Alanyl-D-Isoglutamine and an Oligomer Prepared by Cross-Linking with Glutaraldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

Enhancement of Nonspecific Immunity to Bacterial Infection by Cord Factor (6,6'MTrehalose Dimycolate)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1981.TB00111.X

10.1111/J.1348-0421.1981.TB00111.X

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference